Immediate Impact

3 from Science/Nature 56 standout
Sub-graph 1 of 24

Citing Papers

Olezarsen, Acute Pancreatitis, and Familial Chylomicronemia Syndrome
2024 Standout
Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia
2024 Standout
3 intermediate papers

Works of T Halmos being referenced

Tesaglitazar, a dual peroxisome proliferator-activated receptor α/γ agonist, improves apolipoprotein levels in non-diabetic subjects with insulin resistance
2007
Tesaglitazar, a novel dual peroxisome proliferator-activated receptor α/γ agonist, dose-dependently improves the metabolic abnormalities associated with insulin resistance in a non-diabetic population
2005

Author Peers

Author Last Decade Papers Cites
T Halmos 101 146 170 102 33 361
Xiaolong Zhao 58 119 125 77 32 387
Takatoshi Anno 65 116 145 105 45 355
Eleni P. Kotanidou 70 125 79 77 46 408
Yueye Huang 117 153 110 75 24 405
Yuzhen Liang 71 125 111 55 29 395
Rufei Shen 85 123 107 65 19 310
Farah Lizotte 76 70 173 83 22 403
Jin Shang 61 73 168 118 22 366
Dongjuan Zhang 68 66 137 64 28 320
Hind Berrahmoune 81 69 130 71 24 403

All Works

Loading papers...

Rankless by CCL
2026